ArticleScientific reports2021

Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay.

Shiqin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.